|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.110 USD | -0.96% |
|
-13.66% | -64.72% |
| 08-13 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 08-13 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.96% | -13.66% | -34.76% | -57.41% | -64.72% | -58.61% | -44.76% | - | - | 413M | |
| +0.11% | +2.71% | -3.57% | +10.98% | +1.45% | +0.33% | +28.59% | -27.52% | +200.94% | 46.18B | |
| -1.12% | +1.78% | +10.99% | +58.80% | +18.19% | +40.07% | +27.26% | +3.94% | +244.61% | 44.35B | |
| -3.04% | -6.29% | -11.60% | +17.15% | +139.74% | +322.27% | +517.36% | +511.43% | - | 42.21B | |
| -0.74% | +1.25% | -4.96% | +29.87% | +15.48% | +2.32% | +67.94% | -12.97% | +974.55% | 40.19B | |
| -0.50% | +0.67% | -8.24% | +3.34% | +4.07% | +11.79% | +40.51% | -20.80% | +135.95% | 29.83B | |
| -0.46% | +4.22% | +3.73% | +33.06% | +9.02% | +21.99% | +124.21% | +229.17% | +1,910.94% | 17.17B | |
| -0.97% | -10.17% | -4.87% | +2.55% | - | - | - | - | - | 15.7B | |
| -0.57% | +8.12% | +9.73% | +21.56% | +22.50% | +22.15% | +38.93% | -39.09% | +97.21% | 15.32B | |
| -3.14% | +31.91% | +57.70% | +53.11% | +31.82% | -10.60% | - | - | - | 14.5B | |
| -1.28% | -0.07% | -0.40% | +50.30% | +39.39% | +77.12% | +32.05% | -36.87% | +243.20% | 13.45B | |
| -3.28% | -3.07% | -1.76% | +12.40% | -9.94% | -8.54% | -37.61% | -38.81% | +116.82% | 13.09B | |
| -0.06% | +0.35% | +0.21% | +24.91% | +23.06% | +36.57% | +1.69% | -45.83% | +169.33% | 11.36B | |
| -1.03% | +7.50% | -15.35% | +90.66% | +52.30% | +21.29% | +49.72% | -55.92% | - | 10.98B | |
| +5.70% | +21.57% | +39.21% | +233.67% | +216.75% | +128.19% | +95.24% | +16.74% | +1,454.94% | 10.82B | |
| -0.62% | +2.43% | -2.99% | +30.21% | +51.33% | +130.16% | +516.82% | +87.05% | - | 9.85B | |
| -2.88% | -10.17% | -11.56% | +5.57% | -24.42% | +30.19% | +456.23% | +187.97% | +1,162.14% | 9.38B | |
| -0.49% | -3.50% | -9.11% | +26.71% | +63.73% | +130.13% | +710.20% | +715.74% | +897.91% | 9.3B | |
| -2.37% | +1.95% | +2.39% | +17.27% | -8.46% | -10.01% | -4.31% | -28.56% | +40.53% | 9.18B | |
| -3.71% | -10.65% | -19.17% | +5.89% | +1.43% | +560.96% | +1,303.52% | -0.15% | - | 8.67B | |
| Average | -0.99% | +1.08% | -0.22% | +33.53% | +30.67% | +76.20% | +217.98% | +85.03% | +588.39% | 18.6B | |
| Weighted average by Cap. | -1.01% | +1.99% | +0.56% | +33.01% | +36.03% | +75.48% | +174.95% | +87.14% | +518.29% |
- Stock Market
- Stocks
- SPRY Stock
- Sector ARS Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
